Multimodal lifestyle intervention consistently improves cognition in early dementia

For patients with early Alzheimer's disease and mild cognitive impairment, cognition is consistently improved with multimodal ...
Applied Clinical Trials Online

Cochrane Review of Anti-Amyloid Alzheimer's Drug Trials Draws Sharp Criticism From Field

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...
Nasdaq

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild AD Improvement in cognition measured by ADAS-Cog 11 at three months is ...
ABC News

Excercise May Help Prevent Age-Related Memory Loss

Sept. 2 -- TUESDAY, Sept. 2 (HealthDay News) -- Exercise may help treat memory problems in adults, according to new research from Australia. The study, focused on 138 people age 50 and older at ...
McKnight's Long-Term Care News

Triple combo of exercise, cognitive training, vitamin D improves cognition, study finds

Aerobic-resistance exercises and computerized cognitive training improved brain power in older adults with mild cognitive impairments. But add vitamin D into the mix — thought to be linked with better ...
Kaleido Scope

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials

Clinical trials in Alzheimer disease (AD) generally allow participants to continue receiving concomitant medications, including cholinesterase inhibitors (ChEIs) and memantine, if the dose is stable.